SS
CTKB icon

SBI Securities’s Cytek Biosciences CTKB Stock Holding History

SBI Securities’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9K Hold
5,010
– – ﹤0.01% 1419
2025
Q4 		$25.3K Buy
5,010
+2,500
+100% +$11.6K ﹤0.01% 1348
2025
Q3 		$8.71K Sell
2,510
-10
-0.4% -$38 ﹤0.01% 1828
2025
Q2 		$8.57K Buy
2,520
+2,500
+12,500% +$8.33K ﹤0.01% 1769
2025
Q1 		$80 Buy
20
+10
+100% +$52 ﹤0.01% 3517
2024
Q4 		$65 Buy
+10
New +$60 ﹤0.01% 3574

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBI Securities's CTKB Position: Q1 2026 in Review

SBI Securities held its Cytek Biosciences (CTKB) position steady in Q1 2026 at 5,010 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

SBI Securities first reported a position in CTKB in Q4 2024 and has held it in 6 quarters since. The position peaked at $25.3K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • SBI Securities held 5,010 shares of Cytek Biosciences worth $21.9K as of Q1 2026.
  • SBI Securities left its Cytek Biosciences share count unchanged in Q1 2026.
  • Cytek Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1419 holding.
  • SBI Securities first reported a position in Cytek Biosciences in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Cytek Biosciences position peaked at $25.3K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.